Andrea Casadei Gardini, MD, IRST-IRCCS presenting "Abstract 230: eNOS polymorphisms in relation to outcome in advanced HCC patients receiving sorafenib"
San Francisco, CA - 2015 Gastrointestinal Cancers Symposium : Andrea Casadei Gardini, MD, IRST-IRCCS presenting "Abstract 230: eNOS polymorphisms in relation to outcome in advanced HCC patients receiving sorafenib" during Welcome and General Session 4: Ordering Molecular Profiling for Patients: Are We Ready at the Gastrointestinal Cancers Symposium 2015 here today, Friday January 16, 2015. The Symposium is supported by ASCO, the American Society of Clinical Oncology, ASTRO, The American Society of Radiation Oncology, SSO, Society of Surgical Oncology and the AGA Institute. Over 3,000 physicians, researchers and allied healthcare professionals are attending the meeting which is being held at the Moscone West center in San Francisco and features the latest Gastrointestinal Cancers research in the areas of basic and clinical science. Date: Friday January 16, 2015. Photo by © ASCO/Todd Buchanan 2015 Technical Questions: email@example.com; Phone: 612-226-5154. GI15_DailyNews